Browsing Category
Pharma Industry News
4743 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Can AI fix peptide drug development’s biggest bottlenecks—permeability and stability?
AI is transforming peptide drug design by tackling stability and permeability challenges. Find out how platforms like Atombeat are changing the rules.
Why Hemispherian’s FDA-cleared GLIX1 trial could be a turning point for brain cancer therapy
Hemispherian gets FDA clearance for GLIX1 Phase 1 trial in glioblastoma. Find out how this novel therapy targets DNA repair to combat deadly brain tumors.
Why Shilpa’s bet on Alveolus Bio may reshape the future of pulmonary biologics
Shilpa Medicare leads funding round in Alveolus Bio to accelerate Phase 2 COPD trials and first-in-human studies for novel inhaled therapeutics.
Can Atombeat and BioDuro’s trillion-compound AI engine transform peptide drug discovery in 2025?
Find out how Atombeat and BioDuro are using AI to revolutionize peptide drug discovery with faster timelines and lower R&D costs.
Why Rocket Pharmaceuticals shareholders are filing suit over adverse event risks in RP-A501
A class action lawsuit claims Rocket Pharmaceuticals misled investors about the safety and effectiveness of its gene therapy. Find out what’s at stake.
Exicure completes Phase 2 trial of GPC-100 for stem cell mobilization in multiple myeloma patients
Exicure (NASDAQ: XCUR) completes final patient visit in Phase 2 GPC-100 trial for stem cell mobilization in multiple myeloma; topline results expected Q4 2025.
Can Sanofi turn molecular clamp technology into a global respiratory vaccine platform beyond RSV?
Can Sanofi turn Vicebio’s molecular clamp tech into a global respiratory vaccine platform? Analysts see multi-pathogen potential beyond RSV by 2030.
How much could Vicebio’s $1.15bn acquisition add to Sanofi’s RSV market share by 2030?
Can Sanofi’s $1.15B Vicebio deal help it win 10% of the RSV market by 2030? Analysts weigh in on how combination vaccines could change respiratory care.
Why paediatric therapies could be Jagsonpal Pharmaceuticals’ next big growth driver in FY26
Jagsonpal Pharmaceuticals is scaling paediatric therapies, aiming to capture gut health, cough, and anti-diarrhoeal demand as child healthcare awareness rises in India.
IntraBio’s AQNEURSA earns positive CHMP opinion, bringing Niemann-Pick disease type C therapy closer to EU approval
IntraBio’s AQNEURSA earns positive CHMP opinion for Niemann-Pick disease type C, moving closer to EU approval after strong Phase III data and U.S. FDA nod.